PHENIXFIN CORP (PFX) Stock Fundamental Analysis

NASDAQ:PFX • US71742W1036

44 USD
+1.22 (+2.85%)
Last: Feb 18, 2026, 10:14 AM
Fundamental Rating

2

PFX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. PFX may be in some trouble as it scores bad on both profitability and health. PFX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • PFX had negative earnings in the past year.
  • PFX had a negative operating cash flow in the past year.
  • PFX had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: PFX reported negative operating cash flow in multiple years.
PFX Yearly Net Income VS EBIT VS OCF VS FCFPFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • With a Return On Assets value of 1.31%, PFX is not doing good in the industry: 65.82% of the companies in the same industry are doing better.
  • The Return On Equity of PFX (2.58%) is worse than 68.78% of its industry peers.
  • PFX has a Return On Invested Capital of 1.31%. This is in the lower half of the industry: PFX underperforms 64.13% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PFX is significantly below the industry average of 7.29%.
Industry RankSector Rank
ROA 1.31%
ROE 2.58%
ROIC 1.31%
ROA(3y)6.23%
ROA(5y)3.3%
ROE(3y)10.85%
ROE(5y)5.68%
ROIC(3y)1.6%
ROIC(5y)2.55%
PFX Yearly ROA, ROE, ROICPFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • The Profit Margin of PFX (16.45%) is comparable to the rest of the industry.
  • PFX has a Operating Margin (20.35%) which is in line with its industry peers.
  • PFX's Operating Margin has declined in the last couple of years.
  • PFX has a better Gross Margin (59.31%) than 66.24% of its industry peers.
  • In the last couple of years the Gross Margin of PFX has grown nicely.
Industry RankSector Rank
OM 20.35%
PM (TTM) 16.45%
GM 59.31%
OM growth 3Y-2.47%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.03%
GM growth 5Y129.57%
PFX Yearly Profit, Operating, Gross MarginsPFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

3

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, PFX has less shares outstanding
  • PFX has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PFX has a worse debt to assets ratio.
PFX Yearly Shares OutstandingPFX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
PFX Yearly Total Debt VS Total AssetsPFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • PFX has an Altman-Z score of -1.94. This is a bad value and indicates that PFX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.94, PFX is doing worse than 88.19% of the companies in the same industry.
  • PFX has a Debt/Equity ratio of 0.92. This is a neutral value indicating PFX is somewhat dependend on debt financing.
  • PFX's Debt to Equity ratio of 0.92 is in line compared to the rest of the industry. PFX outperforms 51.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z -1.94
ROIC/WACCN/A
WACCN/A
PFX Yearly LT Debt VS Equity VS FCFPFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.15 indicates that PFX should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.15, PFX is in line with its industry, outperforming 52.32% of the companies in the same industry.
  • A Quick Ratio of 1.15 indicates that PFX should not have too much problems paying its short term obligations.
  • PFX's Quick ratio of 1.15 is in line compared to the rest of the industry. PFX outperforms 56.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
PFX Yearly Current Assets VS Current LiabilitesPFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

  • The earnings per share for PFX have decreased strongly by -116.81% in the last year.
  • Looking at the last year, PFX shows a quite strong growth in Revenue. The Revenue has grown by 13.89% in the last year.
  • Measured over the past years, PFX shows a small growth in Revenue. The Revenue has been growing by 3.28% on average per year.
EPS 1Y (TTM)-116.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-295.08%
Revenue 1Y (TTM)13.89%
Revenue growth 3Y17.68%
Revenue growth 5Y3.28%
Sales Q2Q%7.25%

3.2 Future

  • PFX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.02% yearly.
  • PFX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.42% yearly.
EPS Next Y-27.22%
EPS Next 2Y-12.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.89%
Revenue Next 2Y-3.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PFX Yearly Revenue VS EstimatesPFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
PFX Yearly EPS VS EstimatesPFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20

0

4. Valuation

4.1 Price/Earnings Ratio

  • PFX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 25.49 indicates a quite expensive valuation of PFX.
  • PFX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PFX is more expensive than 63.29% of the companies in the same industry.
  • PFX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 25.49
PFX Price Earnings VS Forward Price EarningsPFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFX Per share dataPFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • A cheap valuation may be justified as PFX's earnings are expected to decrease with -12.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.02%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for PFX!.
Industry RankSector Rank
Dividend Yield 0%

PHENIXFIN CORP

NASDAQ:PFX (2/18/2026, 10:14:16 AM)

44

+1.22 (+2.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners28.15%
Inst Owner Change-3%
Ins Owners21.15%
Ins Owner Change1.02%
Market Cap88.00M
Revenue(TTM)25.26M
Net Income(TTM)4.16M
Analysts45
Price TargetN/A
Short Float %0.02%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.44
Dividend Growth(5Y)N/A
DP69.5%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)219.72%
Min EPS beat(2)-298.02%
Max EPS beat(2)737.46%
EPS beat(4)2
Avg EPS beat(4)110.62%
Min EPS beat(4)-298.02%
Max EPS beat(4)737.46%
EPS beat(8)6
Avg EPS beat(8)137.87%
EPS beat(12)10
Avg EPS beat(12)203.89%
EPS beat(16)12
Avg EPS beat(16)389.97%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)1.27%
Max Revenue beat(2)16.88%
Revenue beat(4)3
Avg Revenue beat(4)4.07%
Min Revenue beat(4)-8.6%
Max Revenue beat(4)16.88%
Revenue beat(8)6
Avg Revenue beat(8)9.97%
Revenue beat(12)9
Avg Revenue beat(12)9.09%
Revenue beat(16)13
Avg Revenue beat(16)10.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.49
P/S 3.48
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)1.73
Fwd EY3.92%
FCF(TTM)-33.66
FCFYN/A
OCF(TTM)-33.66
OCFYN/A
SpS12.63
BVpS80.39
TBVpS80.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 2.58%
ROCE 1.66%
ROIC 1.31%
ROICexc 1.35%
ROICexgc 1.35%
OM 20.35%
PM (TTM) 16.45%
GM 59.31%
FCFM N/A
ROA(3y)6.23%
ROA(5y)3.3%
ROE(3y)10.85%
ROE(5y)5.68%
ROIC(3y)1.6%
ROIC(5y)2.55%
ROICexc(3y)1.76%
ROICexc(5y)3.28%
ROICexgc(3y)1.76%
ROICexgc(5y)3.3%
ROCE(3y)2.03%
ROCE(5y)3.23%
ROICexgc growth 3Y-4.13%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.03%
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.03%
GM growth 5Y129.57%
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.59
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z -1.94
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-295.08%
EPS Next Y-27.22%
EPS Next 2Y-12.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.89%
Revenue growth 3Y17.68%
Revenue growth 5Y3.28%
Sales Q2Q%7.25%
Revenue Next Year-2.89%
Revenue Next 2Y-3.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.67%
EBIT growth 3Y14.77%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-518.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-518.06%
OCF growth 3YN/A
OCF growth 5YN/A

PHENIXFIN CORP / PFX FAQ

What is the ChartMill fundamental rating of PHENIXFIN CORP (PFX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PFX.


What is the valuation status for PFX stock?

ChartMill assigns a valuation rating of 0 / 10 to PHENIXFIN CORP (PFX). This can be considered as Overvalued.


How profitable is PHENIXFIN CORP (PFX) stock?

PHENIXFIN CORP (PFX) has a profitability rating of 2 / 10.


What is the financial health of PHENIXFIN CORP (PFX) stock?

The financial health rating of PHENIXFIN CORP (PFX) is 3 / 10.


What is the earnings growth outlook for PHENIXFIN CORP?

The Earnings per Share (EPS) of PHENIXFIN CORP (PFX) is expected to decline by -27.22% in the next year.